✦ LIBER ✦

Is Edentulism Associated with Lower Bacteremia and Transplant-Associated Toxicities in Patients with Multiple Myeloma?

✍ Scribed by Toro, Juan J.; Schneider, Deanna; Lee, Shuko; Smith, Gregory M.; Gushiken, Francisca; Haile, David J.; Freytes, Cesar O.

Book ID: 123451691
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 47 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2012.11.376

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Persistency with zoledronic acid is asso

Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma

✍ Henry J. Henk; April Teitelbaum; Jose Ricardo Perez; Satyin Kaura 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB

Decreased body mass index is associated

Decreased body mass index is associated with poor prognosis in patients with multiple myeloma

✍ Jung, Sung-Hoon; Yang, Deok-Hwan; Ahn, Jae-Sook; Lee, Seung-Shin; Ahn, Seo-Yeon; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 159 KB

Response to bortezomib is associated to

Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma

✍ Maurizio Zangari; Dixie Esseltine; Choon-Kee Lee; Bart Barlogie; Francesca Elice 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Reduced-intensity conditioning allogenei

Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients

✍ Pérez-Simón, J A; Sureda, A; Fernández-Aviles, F; Sampol, A; Cabrera, J R; Cabal 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

Fusion Cell Vaccination In Conjunction W

Fusion Cell Vaccination In Conjunction With Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and Is Associated With Responses In Patients With Multiple Myeloma

✍ D. Avigan; J. Rosenblatt; B. Vasir; Z. Wu; A. Bissonnette; P. Somaiya; C. MacNam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Erythropoiesis stimulating agents are as

Erythropoiesis stimulating agents are associated with reduced survival in patients with multiple myeloma

✍ Eirini Katodritou; Evgenia Verrou; Christina Hadjiaggelidou; Vassiliki Gastari; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

## Abstract The impact of erythropoiesis‐stimulating agent (ESA) on cancer patients' survival has recently become a matter of extensive discussion. Studies in solid tumors demonstrated that ESA adversely affects survival. This issue has not been sufficiently studied in patients with multiple myelom